# SynergEyes

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synergeyes

- Industry: Medical Devices & Equipment
- Headquarters: Carlsbad, US
- Website: www.synergeyes.com
- Total disclosed funding: $45M
- Latest round: Series D (May 27, 2014)
- Investors on record: 6

## About

SynergEyes Inc. is a company specializing in the design and manufacture of innovative specialty contact lenses focused on hybrid lens technology, providing comfort and optical clarity for diverse vision needs.Founded in 2001, SynergEyes Inc. is headquartered in Carlsbad, US, and specializes in hybrid contact lens technology. The company has undergone strategic pivots and was acquired by The Cooper Companies, Inc. in November 2022 for an undisclosed amount, which aims to enhance specialty lens adoption in North America. Under the leadership of CEO Bob Ferrigno, SynergEyes has raised a total of USD 3.53 mn across 8 deals, with the latest funding round being Series E on November 3, 2022, providing a current company valuation of USD 66.396 mn.SynergEyes designs and manufactures innovative specialty contact lenses, emphasizing hybrid lens technology that merges the comfort of soft lenses with the optical clarity of gas permeable lenses. Their key products include SynergEyes iD, Duette, and UltraHealth, which address the needs of patients with astigmatism, presbyopia, and conditions like keratoconus. These lenses are marketed across North America, Europe, and parts of Asia, aiming to enhance visual acuity and comfort for a wide range of users.SynergEyes operates on a direct sales model to eye care professionals, who then distribute the specialty lenses to consumers. This B2B approach facilitates partnerships with optometrists, allowing them to recommend products like the Duette and UltraHealth lenses tailored to individual patient needs. Bulk orders from practitioners enable efficient stock management and accessibility of these lenses, while pricing agreements with healthcare professionals ensure a focus on quality and performance in meeting optical requirements.Following its acquisition in November 2022, SynergEyes plans to leverage its new partnership with The Cooper Companies, Inc. to expand the adoption of specialty contact lenses in North America. The company is expected to enhance its product line with new offerings tailored for emerging market demands and may look to increase its geographic presence in Asia. Recent funding will support these initiatives, fostering growth and innovation in their product development strategy, with an emphasis on new product launches.

## Funding rounds

- Series D, May 27, 2014, $2M — Delphi Ventures, De Novo Ventures, BioStar Capital, Windward Ventures
- Series C, Oct 9, 2008, $13M — Alloy Ventures, Delphi Ventures, InnoCal, De Novo Ventures, BioStar Capital, Windward Ventures
- Series B, Apr 13, 2006, $16M — Alloy Ventures, Delphi Ventures, InnoCal, De Novo Ventures, Windward Ventures
- Series A, Dec 22, 2004, $14M — InnoCal

## Investors

- InnoCal (https://capitalatlas.ai/funds/innocal) — Series A, Series B, Series C
- Alloy Ventures (https://capitalatlas.ai/funds/alloy-ventures) — Series B, Series C
- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series B, Series C, Series D
- De Novo Ventures (https://capitalatlas.ai/funds/de-novo-ventures) — Series B, Series C, Series D
- Windward Ventures (https://capitalatlas.ai/funds/windward-ventures) — Series B, Series C, Series D
- BioStar Capital (https://capitalatlas.ai/funds/biostar-capital) — Series C, Series D